PCP
AMED

Pacific Capital Partners’s Amedisys AMED Stock Holding History

Pacific Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,457
Closed -$623K – 52
2024
Q3 		$623K Hold
6,457
– – 0.37% 51
2024
Q2 		$593K Hold
6,457
– – 0.39% 56
2024
Q1 		$595K Hold
6,457
– – 0.39% 55
2023
Q4 		$614K Hold
6,457
– – 0.46% 51
2023
Q3 		$603K Buy
+6,457
New +$597K 0.36% 48

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Pacific Capital Partners's AMED Position: Q4 2024 in Review

Pacific Capital Partners sold out of Amedisys (AMED) in Q4 2024, closing a stake of 6,457 shares — an estimated $623K sold.

Pacific Capital Partners first reported a position in AMED in Q3 2023 and held it in 5 quarters. The position peaked at $623K in Q3 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Pacific Capital Partners reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Pacific Capital Partners sold 6,457 Amedisys shares in Q4 2024, an estimated $623K.
  • Pacific Capital Partners first reported a position in Amedisys in Q3 2023 and held it in 5 quarters.
  • Pacific Capital Partners's Amedisys position peaked at $623K in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Pacific Capital Partners's 13F filing for Q4 2024, filed 8 May 2025.